March 2021 • PharmaTimes Magazine • 3
This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration. As the analysis shows, a relentless focus on innovation and a determination to solve problems hindering patient outcomes are key traits that have helped those at the top shine in a sector that saw average growth of 33% in 2020. Taking top-spot in the ranking, Exscientia has almost quadrupled its revenue in the last two years, a remarkable achievement and even more so considering the current climate. Turn to page 20 for an in-depth look at the other companies reaching new heights and what’s fuelling their success.
Elsewhere, on page 17, John Pinching and three pharma experts discuss the nature of the relationship between the pharma industry and the NHS and the catalysts for a new dynamic between these two giants of healthcare, while on page 28 the team at Veeva outline their expectations for the life sciences industry in 2021.
We also take another look at the microbiome and the growing realisation of its importance in several disease states and promise in the development of new targeted therapies. On page 38, Anthony Finbow describes how the science of microbiomes will increasingly contribute to research outcomes, while on page 40 Dr Tom Williams provides a close look at the relationship between the microbiome and melanoma.
Selina McKee
editor
PharmaTimes Media Ltd,
Mansard House, Church Road,
Little Bookham, Surrey, KT23 3JG
Tel: +44 (0)20 7240 6999
www.pharmatimes.com
Twitter: @PharmaTimes
EDITORIAL
Selina McKee / editor
selina.mckee@pharmatimes.com
Karl Equi / executive director
karl.equi@pharmatimes.com
SALES & MARKETING
Anna Yeardley / business manager
anna.yeardley@pharmatimes.com
SUBSCRIPTIONS/REPRINTS
Digital and paper copies available
free to qualifying readers:
www.pharmatimes.com/subscribe
Tel: 01372 414 222
subscriptions@pharmatimes.com
Paper subscriptions available at £90.00 UK
and £100.00 overseas per annum.
Views expressed by the contributors
do not necessarily represent those of
the publisher, editor or staff.
Material may not be reproduced in any form
without the publisher’s written permission.
© Copyright 2021 PharmaTimes Magazine.
All rights reserved. PharmaTimes Magazine
is published by PharmaTimes Media Ltd,
which is registered as a limited company
in England; No 09019637.
You can help shape these articles. For more information,
please email Anna Yeardley anna.yeardley@pharmatimes.com